Charles Rhyee
Stock Analyst at TD Cowen
(0.08)
# 3,715
Out of 4,829 analysts
52
Total ratings
20%
Success rate
-45.4%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $140.80 | +11.51% | 4 | Apr 14, 2025 | |
| MEDP Medpace Holdings | Downgrades: Hold | $370 → $328 | $314.09 | +4.43% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $148.49 | -3.02% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $142.99 | +58.75% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $5.24 | +377.10% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $7.36 | +8.70% | 6 | Oct 31, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $241.28 | -20.42% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.31 | +271.23% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $3.07 | +62.87% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $7.21 | +593.48% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $156.02 | +60.88% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $5.19 | +979.00% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.75 | +1,758.24% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $9.25 | +440.83% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $687.21 | -47.47% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.69 | +191,615.98% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $23.00 | +52.17% | 1 | Feb 13, 2018 |
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $140.80
Upside: +11.51%
Medpace Holdings
Apr 14, 2025
Downgrades: Hold
Price Target: $370 → $328
Current: $314.09
Upside: +4.43%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $148.49
Upside: -3.02%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $142.99
Upside: +58.75%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $5.24
Upside: +377.10%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $7.36
Upside: +8.70%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $241.28
Upside: -20.42%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.31
Upside: +271.23%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.07
Upside: +62.87%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $7.21
Upside: +593.48%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $156.02
Upside: +60.88%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $5.19
Upside: +979.00%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.75
Upside: +1,758.24%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $9.25
Upside: +440.83%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $687.21
Upside: -47.47%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.69
Upside: +191,615.98%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $23.00
Upside: +52.17%